BioStock: Founder and CTO on Iconovo’s journey

The inhalation company Iconovo was founded in 2013 by several people with extensive experience in the development and commercialization of inhalation drugs. Today, the company has four patent-protected inhalation platforms, nine development agreements with international pharma companies and over 30 employees. BioStock interviewed Orest Lastow, co-founder and CTO, about Iconovo’s journey from the start to now.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/10/founder-and-cto-on-iconovos-journey/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/